| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.28 | 0.002 |